MichioHiranoMD

Neuromuscular Medicine

Professor, Pathology; Neuroscience, Albert Einstein College of Medicine

Overview of Dr. Hirano

Dr. Michio Hirano is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 31 years. Dr. Hirano accepts several types of health insurance, listed below. He is one of 482 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 100 publications and over 500 citings.

Office
710 W 168th St
New York, NY 10032
Book by Phone+1(706) 810-9910

Fax+1 212-305-1304

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1987 - 1990
Jacobi Medical CenterInternship, Transitional Year, 1986 - 1987
Albert Einstein College of MedicineClass of 1986
New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuromuscular Medicine (Neurology)

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 1987 - 2026
NJ State Medical License 2017 - 2025
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes Start of enrollment: 2009 May 01
Completed
Phase 2
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Start of enrollment: 2010 Dec 01
Recruiting
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE) Start of enrollment: 2013 Feb 01
Recruiting
Alpers Huttenlocher Natural History Study Start of enrollment: 2014 Jan 01
Terminated
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine Start of enrollment: 2017 May 16
Active, not recruiting
Phase 1, Phase 2
A RETROspective Study of Patients With TK2d Start of enrollment: 2018 Nov 19
Completed
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency Start of enrollment: 2019 Jul 05
Active, not recruiting
Phase 2
Natural History Study of MNGIE Start of enrollment: 2020 Aug 06
Suspended
Join now to see all

Publications & Presentations

PubMed

Characterization of Factors Associated With Death in Deceased Patients With Mitochondrial Disorders: A Multicenter Cross-Sectional Survey.
Alina Ivaniuk, Irina A Anselm, Aaron Bowen, Bruce H Cohen, Fatma Tuba Eminoglu
Neurology. 2025-02-25
Basic Science and Pathogenesis.
Weichen Zhou, Kalpita R Karan, Wenjin Gu, Hans-Ulrich Klein, Gabriel Sturm
Alzheimer's & Dementia. 2024-12-01
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease.
Agustin Hidalgo-Gutierrez, Jonathan Shintaku, Javier Ramon, Eliana Barriocanal-Casado, Alba Pesini
Annals of Neurology. 2024-12-01

Journal Articles

A Novel Complex Neurological Phenotype Due to a Homozygous Mutation in FDX2
Michio Hirano, MD, Brain

Press Mentions

Senior Researcher Spotlight: Fernando Scaglia Explores Novel Therapeutic Approaches for Mitochondrial DisordersJune 7th, 2022
Consortium Spotlight: Advancing Discoveries in Mitochondrial DiseasesJune 1st, 2022
Association of American Physicians Honors Seven Physician-ScientistsApril 9th, 2021
Join now to see all

Professional Memberships

American Academy of Neurology - AAN
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment